Guidelines for Minimally Invasive Anti-Tumor Defense Management in the Diagnosis and Treatment of Endometrial Cancer (2025 Edition)
Abstract：1 Background
Endometrial cancer (EC) is a common malignant tumor of the female reproductive system. The incidence has been increasing year by year over the past 10 years, and the age of onset is becoming younger. In 2022, there were 77,700 new cases in China, with 13,500 deaths [1]. In some economically developed cities, the incidence has exceeded that of cervical cancer, becoming the most common gynecological malignancy.
Keywords：endometrial cancerminimally invasive procedures and tumor free strategytumor-free principleclinical guideline
Publication Date：2025-09-02
Online Publishing Date：2025-10-20(First online date of this platform, not the publication date of the document)
Pages：9( 905-913 )